CHM 4.17% 1.2¢ chimeric therapeutics limited

25m not enough

  1. 333 Posts.
    Whilst Chameleon notes the timeframe identified by MMX, Chameleon will act in the best interests of its shareholders.


    $25M is a far better starting place than we've had previously but I don't view it as an ending place, please correct me if I'm mistaken but I thought we're chasing 25% of Jacks Hills which makes up 50% or so of what MMX is receiving.

    CHM is not under any obligation to help MMX meet a self imposed deadline.

    Things are finally getting interesting.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.